Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection

AIDS Patient Care and STDs

Volumn 22, Issue 10, 2008, Pages 811-816

  Milan, Felise B ^a,b   Arnsten, Julia H ^a   Klein, Robert S ^a   Schoenbaum, Ellie E ^a   Moskaleva, Galina ^a   Buono, Donna ^a   Webber, Mayris P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GARLIC EXTRACT; ILLICIT DRUG; PROTEINASE INHIBITOR; SILYBUM MARIANUM EXTRACT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CITY; DIET SUPPLEMENTATION; DRUG ABUSE; ETHNICITY; FEMALE; FINANCIAL MANAGEMENT; GARLIC; GENDER; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MULTIVARIATE ANALYSIS; PRESCRIPTION; PREVALENCE; PROPHYLAXIS; RACE DIFFERENCE; SOYBEAN; URBAN POPULATION;

ADULT; COMPLEMENTARY THERAPIES; DATA COLLECTION; DIETARY SUPPLEMENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; QUESTIONNAIRES; RISK; URBAN POPULATION;

EID: 53849098923     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2007.0159     Document Type: Article

References (49)

1. Bica I, Tang AM, Skinner S, et al. Use of complementary and alternative therapies by patients with human immunodeficiency virus disease in the era of highly active antiretroviral therapy. J Altern Complement Med 2003;9:65-76.
2. Duggan J, Peterson WS, Schutz M, et al. Use of complementary and alternative therapies in HIV-infected patients. AIDS Patient Care STDs 2001;15:159-167.
3. Fairfield KM, Eisenberg DM, Davis RB, et al. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med 19989;158:2257-2264.
4. Furler MD, Einarson TR, Walmsley S, et al. Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada. AIDS Patient Care STDs 2003;17:155-168.
5. Gore-Felton C, Vosvick M, Power R, et al. Alternative therapies: A common practice among men and women living with HIV. J Assoc Nurses AIDS Care 2003;14:17-27.
6. Hsiao AF, Wong MD, Kanouse DE, et al. Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients. J Acquir Immune Defic Syndr 2003;33:157-165.
7. Mikhail IS, DiClemente R, Person S, et al. Association of complementary and alternative medicines with HIV clinical disease among a cohort of women living with HIV/AIDS. J Acquir Immune Defic Syndr 2004;37:1415-1422.
8. Singh N, Squier C, Sivek C, et al. Determinants of nontraditional therapy use in patients with HIV infection. A prospective study. Arch Intern Med 1996;156:197-201.
9. Standish LJ, Greene KB, Bain S, et al. Alternative medicine use in HIV-positive men and women: demographics, utilization patterns and health status. AIDS Care 2001;13:197-208.
10. de Visser R, Ezzy D, Bartos M. Alternative or complementary? Nonallopathic therapies for HIV/AIDS. Altern Ther Health Med 2000;6:44-52.
11. London AS, Foote-Ardah CE, Fleishman JA, Shapiro MF. Use of alternative therapists among people in care for HIV in the United States. Am J Public Health 2003;93:980-987.
12. Dhams S, Shah V, Hirsch S, Banerji MA. The role of complementary and alternative medicine in diabetes. Curr Diab Rep 2006;6:251-258.
13. Nahleh Z, Tabbara IA. Complementary and alternative medicine in breast cancer patients. Palliat Support Care 2003;1:267-273.
14. Sparber A, Wooton JC. Surveys of complementary and alternative medicine Part II: Use of alternative and complementary cancer therapies. J Altern Complement Med 2001;7:281-287.
15. Zick SM, Blume A, Aaronson KD. The prevalence and pattern of CAM use in individuals with chronic heart failure. J Card Fail 2005;11:586-589.
16. Eisenberg D, Kessler RC, Foster C, et al. Unconventional medicine in the United States-prevalence cost and patterns of use. N Engl J Med 1993;328:246-252.
17. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the U.S. 1990-1997. JAMA 1998;280:1569-1575.
18. Druss BG, Rosenheck RA. Association between use of unconventional therapies and conventional medical services. JAMA 1999;282:651-656.
19. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States 2002. Adv Data 2004;343:1-19.
20. National Center for Complementary and Alternative Medicine Website. http://nccam.nih.gov/health/whatiscam/#tcm (Last accessed July 2007).
21. Berg KM, Demas PA, Howard AA, et al. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004;19:1111-1117.
22. Knippels HM, Weiss JJ. Use of alternative medicine in a sample of HIV-positive gay men: An exploratory study of prevalence and user characteristics. AIDS Care 2000;12:435-446.
23. Owen-Smith A, Diclemente R, Wingood G. Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women. AIDS Care 2007;19:589-593.
24. Mills E, Montori V, Perri D, et al. Natural health product-HIV drug interactions: a systematic review. Int J STD AIDS 2005;16:181-186.
25. Ernst E. Complementary AIDS therapies: The good, the bad and the ugly. Int J STD AIDS 1997;8:281-285.
26. Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134-138.
27. Hu Z, Yang X, Ho PC, et al. Herb-drug interactions: a literature review. Drugs 2005;65:1239-1282.
28. Ernst E. Harmless herbs? A review of the recent literature. Am J Med 1998;104:170-178.
29. Slain D, Amsden JR, Khakoo RA, et al. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers. Pharmacotherapy 2005;25:165-170.
30. Piscitelli SC, Burnstein AH, Welden N, et al. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002;34:234-238.
31. Piscitelli SC, Formentini E, Burnstein AH, et al. Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers. Pharmacotherapy 2002;22:551-556.
32. Piscitelli SC, Burstein AH, Chaitt D, et al. Indinavir concentrations and St John's wort. Lancet 2000;355:547-548.
33. Leonard B, Huff H, Merryweather B, et al. Knowledge of safety and herb-drug interations amongst HIV+ individuals: A focus group study. Can J Clin Pharmacol 2004;11:e227-231.
34. Jernewall N, Zea MC, Reisen CA, Poppen PJ. Complementary and alternative medicine and adherence to care among HIV-positive Latino gay and bisexual men. AIDS Care 2005;17:601-609.
35. Klein RS, Lo Y, Santoro N, Dobs AS. Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis 2005;41:1794-1803.
36. Miller SA, Santoro N, Lo Y, et al. Menopause symptoms in HIV-infected and drug-using women. Menopause 2005;12:348-356.
37. Brown ER. California Health Interview Survey, Complementary and Alternative Medicine Questionnaire [online]. www.chis.ucla.edu (Last accessed October 2003).
38. Pawluch D, Cain R, Gillett J. Lay constructions of HIV and complementary therapy use. Soc Sci Med 2000;51:251-264.
39. Cotton S, Puchalski CM, Sherman SN, et al. Spirituality and religion in patients with HIV/AIDS. J Gen Intern Med 2006;21:S5-13.
40. Lorenz KA, Hays RD, Shapiro MF, et al. Religiousness and spirituality among HIV-infected Americans. J Palliat Med 2005;8:774-781.
41. Parsons SK, Cruise PL, Davenport WM, Jones V. Religious beliefs, practices and treatment adherence among individuals with HIV in the southern United States. AIDS Patient Care STDs 2006;20:97-111.
42. Ironson G, Stuetzle R, Fletcher MA. An increase in religousness/ spirituality occurs after HIV diagnosis and predicts slower progression over 4 years in people with HIV. J Gen Intern Med 2006;21(Suppl 5):S62-68.
43. Fitzpatrick AL, Standish LJ, Berger J, Kim JG, Calabrese C, Polissar N. Survival in HIV-1-positive adults practicing psychological or spiritual activities for one year. Altern Ther Health Med 2007;13:18-20, 22-24.
44. Dorland D. Religious Practices of people with HIV/AIDS. Religious Healing in Boston: Body, Spirit, Community. June 2005. Harvard Divinity School. www.hds.harvard.edu/cswr/resources/print/rhb/body/index.htm (Last assessed September 26, 2006).
45. Brown L, Macintyre K, Trujillo L. Intervention to reduce HIV/AIDS stigma: What have we learned? AIDS Educ Prev 2003;15:49-69.
46. Ostrow MJ, Cornelisse PG, Heath KV, et al. Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:115-120
47. Wintergerst ES, Maggini S, Hornig DH. Immune enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab 2006;50:85-94.
48. Fawzi WW, Msamonga GI, Spiegelman D. A randomized controlled trial of multivitamin supplement and HIV disease progression and mortality. N Engl J Med 2004;351:23-32.
49. Marson B, DeCock KM. Multivitamins, nutrition and antriretroviral therapy for HIV disease in Africa. N Engl J Med 2004;351:78-80.